MedPath

Evaluation of acute and long-term outcomes after implantation of a supera stent in the femoropopliteal artery

Conditions
I70.22
Registration Number
DRKS00031244
Lead Sponsor
niversitäts-Herzzentrum Campus Bad Krozingen - Uniklinikum Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
650
Inclusion Criteria

Patients with peripheral arterial disease (CAD) in clinical stage 1-5 according to Rutherford-Becker classification.
Stenosis (=70% diameter reduction) or occlusion in the femoropopliteal vessel segment confirmed by duplex sonography and/or angiography.
At least one follow-up examination (including duplex sonography and/ or angiography), in a period of at least 12 months after re-intervention.

Exclusion Criteria

Patients with stage 6 PAOD according to Rutherford-Becker classification.
No relevant stenosis of the target lesion (<70% diameter reduction).
No follow-up examinations (including duplex sonography) of the target lesion available for at least 12 months after the index procedure (lost-to-follow-up)

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pimary patency- and Target-Revascularisation rate in a follow-up period of at least 12-50 months
Secondary Outcome Measures
NameTimeMethod
Time to first TLR<br>Minor and/or major amputation on the treated leg in the follow-up period.<br>Amputation free survival<br>Change in clinical symptoms according to the Rutherford-Becker classification <br>Severe cardiovascular events (myocardial infarction, stroke, major amputation, death) in the follow-up period <br>Predictors for re-intervention
© Copyright 2025. All Rights Reserved by MedPath